Agilent Technologies has expanded its collaboration with Monash University Malaysia (MUM) for the establishment of a ...

Experts said that US public health is now at risk after the CDC vaccine panel voted against the widespread recommendation for the hepatitis B vaccine at birth.

Viatris has signed definitive agreements for the sale of its equity stake in Biocon Biologics to Biocon for $815m.

Takeda and Innovent have closed their global partnership for next-generation IO and ADC therapies after fulfilment of ...

Opinions amongst the CDC's ACIP were divided on the continued use of the hepatitis B vaccine in a paediatric population.

The strategic partnership sees two separate financial deals for the pair of oncology assets. Rights to Kelun’s integrin ...

Patient advocacy and industry bodies welcomed the bill’s backing, though it will now need to be passed in the Senate.

Høeg’s appointment to director of the FDA's CDER follows a turbulent period for the department, which has seen five leaders ...

Eli Lilly and Company has received approval from the US FDA for the expanded use of Jaypirca tablets in 100mg and 50mg doses.

With $1.5 billion in drug sales, the US dominated the CKD-HPT, HP and HK market in 2024, representing 59.7% of 7MM sales.

AGC Biologics is set to expand its Cell Line Development Centre of Excellence through a partnership with ATUM.

On 1 December, the fortunes of the UK pharma sector changed radically, with the UK Government becoming the first in the world ...